ID

22331

Beschrijving

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed in Treatment Phase. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Trefwoorden

Versies (1)
  1. 30-05-17 30-05-17 -
Geüploaded op

30 mei 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

Geen commentaren

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Concomitant Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Engels

Concomitant Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulieren  
Concomitant Medication
Beschrijving

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Are there any concomitant medication CHANGES since the start of the study? If "YES", please record all medications below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Beschrijving

Concomitant agent

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
Concomitant Medication Changes
Beschrijving

Concomitant Medication Changes

Alias
UMLS CUI-1
C2347852
Drug name (Trade Name preferred)
Beschrijving

Drug name

Datatype

text

Alias
UMLS CUI [1]
C0013227
SINGLE Dose/ Unit (e.g. 500mg)
Beschrijving

Single dose/Unit

Datatype

float

Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C1960417
Frequency of this Dose (e.g. BID PRN)
Beschrijving

Frequency

Datatype

text

Alias
UMLS CUI [1]
C3476109
Route
Beschrijving

Concomitant Medication Route of Administration

Datatype

text

Alias
UMLS CUI [1]
C2826730
Indication
Beschrijving

Indication

Datatype

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3146298
Start Date/Time
Beschrijving

Start Date Time

Datatype

datetime

Alias
UMLS CUI [1]
C2827019
End Date/Time
Beschrijving

Stop Date

Datatype

datetime

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1522314
Continuing at end of Study?
Beschrijving

Continuing at end of study

Datatype

boolean

Alias
UMLS CUI [1]
C1553904
Terug naar het begin van de pagina

Similar models

Concomitant Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant agent
Item
Are there any concomitant medication CHANGES since the start of the study? If "YES", please record all medications below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
boolean
C2347852 (UMLS CUI [1])
Item Group
Concomitant Medication Changes
C2347852 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Single dose/Unit
Item
SINGLE Dose/ Unit (e.g. 500mg)
float
C2826257 (UMLS CUI [1,1])
C1960417 (UMLS CUI [1,2])
Frequency
Item
Frequency of this Dose (e.g. BID PRN)
text
C3476109 (UMLS CUI [1])
Concomitant Medication Route of Administration
Item
Route
text
C2826730 (UMLS CUI [1])
Indication
Item
Indication
text
C2347852 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Start Date Time
Item
Start Date/Time
datetime
C2827019 (UMLS CUI [1])
Stop Date
Item
End Date/Time
datetime
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1522314 (UMLS CUI [2,2])
Continuing at end of study
Item
Continuing at end of Study?
boolean
C1553904 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial